PortfoliosLab logoPortfoliosLab logo
WDNA vs. IDNA
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

WDNA vs. IDNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree BioRevolution Fund (WDNA) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WDNA achieves a 13.32% return, which is significantly lower than IDNA's 19.52% return.


WDNA

1D
0.49%
1M
8.93%
YTD
13.32%
6M
11.11%
1Y
50.90%
3Y*
5.47%
5Y*
-5.03%
10Y*

IDNA

1D
1.53%
1M
6.29%
YTD
19.52%
6M
16.84%
1Y
54.42%
3Y*
11.16%
5Y*
-8.18%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

WDNA vs. IDNA - Yearly Performance Comparison


2026 (YTD)20252024202320222021
WDNA
WisdomTree BioRevolution Fund
13.32%22.68%-14.18%-2.07%-26.29%-4.92%
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
19.52%17.26%-0.72%-7.63%-42.28%-5.50%

Correlation

The correlation between WDNA and IDNA is 0.89, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.89

Correlation (3Y)
Calculated over the trailing 3-year period

0.89

Correlation (5Y)
Calculated over the trailing 5-year period

0.91

Correlation (All Time)
Calculated using the full available price history since Jun 3, 2021

0.90

The correlation between WDNA and IDNA has been stable across timeframes, ranging from 0.89 to 0.91 - a consistent structural relationship.

WDNA vs. IDNA - Sectors Allocation Comparison


Sectors
WDNA
IDNA

Healthcare

85.0%
99.3%

Basic Materials

6.5%

-

Consumer Defensive

3.0%

-

Energy

1.1%

-

Communication Services

-

-

Consumer Cyclical

-

-

Financial Services

-

-

Industrials

-

0.3%

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

WDNA
85.0%
IDNA
99.3%

Basic Materials

WDNA
6.5%
IDNA

-

Consumer Defensive

WDNA
3.0%
IDNA

-

Energy

WDNA
1.1%
IDNA

-

Communication Services

WDNA

-

IDNA

-

Consumer Cyclical

WDNA

-

IDNA

-

Financial Services

WDNA

-

IDNA

-

Industrials

WDNA

-

IDNA
0.3%

Real Estate

WDNA

-

IDNA

-

Technology

WDNA

-

IDNA

-

Utilities

WDNA

-

IDNA

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WDNA vs. IDNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WDNA
WDNA Risk / Return Rank: 6666
Overall Rank
WDNA Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
WDNA Sortino Ratio Rank: 6666
Sortino Ratio Rank
WDNA Omega Ratio Rank: 5656
Omega Ratio Rank
WDNA Calmar Ratio Rank: 8585
Calmar Ratio Rank
WDNA Martin Ratio Rank: 5959
Martin Ratio Rank

IDNA
IDNA Risk / Return Rank: 7474
Overall Rank
IDNA Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
IDNA Sortino Ratio Rank: 7171
Sortino Ratio Rank
IDNA Omega Ratio Rank: 6060
Omega Ratio Rank
IDNA Calmar Ratio Rank: 8989
Calmar Ratio Rank
IDNA Martin Ratio Rank: 7878
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WDNA vs. IDNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


WDNAIDNADifference
Sharpe ratioReturn per unit of total volatility

-0.22

Sortino ratioReturn per unit of downside risk

-0.22

Omega ratioGain probability vs. loss probability

1.32

1.34

-0.02

Calmar ratioReturn relative to maximum drawdown

4.37

5.13

-0.75

Martin ratioReturn relative to average drawdown

9.80

14.30

-4.50

WDNA vs. IDNA - Sharpe Ratio Comparison

The current WDNA Sharpe Ratio is 1.98, which is comparable to the IDNA Sharpe Ratio of 2.19. The chart below compares the historical Sharpe Ratios of WDNA and IDNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

WDNA vs. IDNA - Drawdown Comparison

The maximum WDNA drawdown since its inception was -58.87%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for WDNA and IDNA.


Loading charts...

Drawdown Indicators


WDNAIDNADifference

Max Drawdown

Largest peak-to-trough decline

-58.87%

-68.26%

+9.39%

Max Drawdown (1Y)

Largest decline over 1 year

-11.70%

-10.66%

-1.04%

Max Drawdown (3Y)

Largest decline over 3 years

-38.25%

-29.46%

-8.79%

Max Drawdown (5Y)

Largest decline over 5 years

-58.87%

-68.26%

+9.39%

Current Drawdown

Current decline from peak

-27.05%

-41.07%

+14.02%

Average Drawdown

Average peak-to-trough decline

-35.56%

-36.28%

+0.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.21%

3.82%

+1.39%

Volatility

WDNA vs. IDNA - Volatility Comparison

WisdomTree BioRevolution Fund (WDNA) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) have volatilities of 7.39% and 7.33%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WDNAIDNADifference

Volatility (1M)

Calculated over the trailing 1-month period

7.39%

7.33%

+0.06%

Volatility (6M)

Calculated over the trailing 6-month period

16.98%

18.45%

-1.47%

Volatility (1Y)

Calculated over the trailing 1-year period

25.90%

24.96%

+0.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.14%

28.47%

-3.33%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.06%

29.51%

-4.45%

WDNA vs. IDNA - Expense Ratio Comparison

WDNA has a 0.45% expense ratio, which is lower than IDNA's 0.47% expense ratio.


Dividends

WDNA vs. IDNA - Dividend Comparison

WDNA's dividend yield for the trailing twelve months is around 4.03%, more than IDNA's 0.90% yield.


PositionTTM2025202420232022202120202019
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
0.90%1.18%0.98%1.04%0.54%0.70%0.26%0.80%
WDNA
WisdomTree BioRevolution Fund
4.03%4.57%0.75%0.80%0.38%0.10%0.00%0.00%

Frequently Asked Questions


WDNA and IDNA have a correlation of 0.89, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

WDNA has higher volatility (7.39%) compared to IDNA (7.33%). In terms of maximum drawdown, WDNA dropped -58.87% vs IDNA's -68.26%.

On 5-year performance, WDNA leads with -5.03% vs -8.18% for IDNA. On fees, WDNA is cheaper at 0.45% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, WDNA has performed better with a -5.03% return vs -8.18%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

WDNA is cheaper with a 0.45% expense ratio, compared with 0.47% for IDNA.

WDNA has the higher dividend yield at 4.03%, compared with 0.90% for IDNA.

WDNA tracks WisdomTree BioRevolution Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: WisdomTree and iShares. Their fees differ too: 0.45% for WDNA and 0.47% for IDNA.

IDNA currently has the higher Sharpe Ratio (2.19 vs 1.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for WDNA and IDNA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer